Vascular function of forearm microcirculation in postmenopausal women with type 2 diabetes: potential benefit of hormone replacement therapy?

References

• Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983;118:489–96
   Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. J Am Med Assoc 1998; 280:605–52
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initia-tive randomized controlled trial. J Am Med Assoc 2002;288:321–33
   Google Scholar
• Watts GF, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 1998;141:17–30
   PubMed Web of Science ®Google Scholar
• Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936–41
   PubMed Web of Science ®Google Scholar
• Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replace-ment therapy on vascular nitric oxide activity. J Clin Endocrinol Metab 2000;85:1577–83
   Google Scholar
• Sorensen KE, Dorup I, Hermann AP, MosekildeL. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234–8
   PubMed Web of Science ®Google Scholar
• Perera M, Sattar N, Petrie JR, et al. The effects of transdermal estradiol in combination withoral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2001;86:1140–3
   PubMed Web of Science ®Google Scholar
• Lim SC, Caballero AE, Arora S, et al. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. J Clin Endocrinol Metab 1999;84:4159–64
   PubMed Web of Science ®Google Scholar
• Perera M, Petrie JR, Hillier C, et al. Hormone replacement therapy can augment vascular relax-ation in postmenopausal women with type 2 diabetes. Hum Reprod 1999;17:497–502
   Google Scholar
• Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998; 158:617–21
   PubMed Web of Science ®Google Scholar
• Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-0 estradiol. Metabolism 1992;41:1110–14
   PubMed Web of Science ®Google Scholar
• Sack MN, Rader DJ, Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269–70
   Google Scholar
• Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor a mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401–6
   Google Scholar
• Williams MRI, Westerman RA, Kingwell BA, et al. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 2001;86:5389–95
   PubMed Web of Science ®Google Scholar
• Al-Khalili F, Eriksson M, Landgren BM, Schenck-Gustafsson K. Effect of conjugatedestrogen on peripheral flow-mediated vaso-dilation in postmenopausal women. Am J Cardiol 1998;82:215–18
   Google Scholar
• Sax FL, Cannon RO III, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a gener-alized disorder of vascular function? N Engl J Med 1987;317:1366–70
   PubMed Web of Science ®Google Scholar
• Nitenberg A, Valensi P, Sachs R, Dati M, Aptecar E, Attati JR. Impairment of coronary vascular reserve and ACh-induced coronary vasoditation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993;42:1017–25
   PubMed Web of Science ®Google Scholar
• Watts GF, Herrmann S, Dogra GK, et al. Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int 2001; 60:182–9
   PubMed Web of Science ®Google Scholar
• Kannet WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447–52
   PubMed Web of Science ®Google Scholar
• Matthews KA, Meitahn E, KuIter LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641–6
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996;28:576–82
   PubMed Web of Science ®Google Scholar
• Playford D, Watts GF. Endothelial dysfunction, insulin resistance and diabetes: exploring the web of causality. Aust NZ J Med 1999;29:523–34
   PubMedGoogle Scholar
• Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–11
   PubMed Web of Science ®Google Scholar
• McCrohon JA, Adams MR, McCredie RJ, et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol 1996;45: 435–41
   PubMed Web of Science ®Google Scholar
• Gerhard M, Walsh BW, Tawakol A, et al. Estradiot therapy combined with progesterone and endothelium-dependent vasoditation in postmenopausal women. Circulation 1998;98: 1158–63
   PubMed Web of Science ®Google Scholar
• Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998;104:552–8
   PubMed Web of Science ®Google Scholar
• Kawano H, Motoyama T, Hirai N, et al. Effect of medroxyprogesterone acetate plus estradiot on endothelium-dependent vasoditationin postmenopausal women. Am J Cardiol 2001; 87:238–40
   PubMed Web of Science ®Google Scholar
• Chan NN, MacAllister RJ, Colhoun HM, Vallance P, Hingorani AD. Changes in endothelium-dependent vasodilatation and a-adrenergic responses in resistance vessels during the menstrual cycle in healthy women. J Clin Endocrinol Metab 2001;86:2499–504
   Google Scholar
• English JL, Jacobs LO, Green G, Andrews TC. Effect of the menstrual cycle on endothelium-dependent vasoditation of the brachial artery in normal young women. Am J Cardiol 1998;82: 256–8
   PubMed Web of Science ®Google Scholar
• Patin SL, Kumar S, Sturdee DW, Barnett AH. Hormone replacement therapy for postmeno-pausal women with diabetes. Diabetes Obesity Metab 2001;3:187–93
   PubMed Web of Science ®Google Scholar
• Kaseta JR, Skafar DF, Ram JL, Jacober SJ, Sowers JR. Cardiovascular disease in the diabetic woman. J Clin Endocrinol Metab 1999;84: 1835–8
   PubMed Web of Science ®Google Scholar
• Higashi Y, Sanada M, Sasaki S, et al. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001;37:651–7
   PubMed Web of Science ®Google Scholar
• Koh KK, Cardillo C, Bui MN, et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmeno-pausal women. Circulation 1999;99:354–60
   PubMed Web of Science ®Google Scholar
• Kawano H, Motoyama T, Hirashima 0, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasoditation of brachial artery. J Am Coll Cardiol 1999;34:146–54
   Google Scholar
• Guetta V, Cannon RO. Cardiovascular effects of estrogen and lipid-lowering therapies in post-menopausal women. Circulation 1995;93: 1928–37
   Web of Science ®Google Scholar
• Playford DA, Watts GF. Non-invasive measure-ment of endothelial function. Clin Exp Pbarma-col Physiol 1998;25:640–3
   PubMed Web of Science ®Google Scholar
• Liu MY, Hattori Y, Fukao M, Sato A, Sakuma I, Kanno M. Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br J Pbarmacol 2001;132:1035–46
   PubMed Web of Science ®Google Scholar
• Mikkola T, Viinikka L, Ylikorkala 0. Adminis-tration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells. Fertil Steril 2000;73:72–4
   Google Scholar